Evaluation of Novel Tools to Facilitate the Detection and Characterization of Leprosy Patients in China
Table 2
Summarized results of three tests evaluated.
Group
Rapid test
ELISA1
WBA2
NDO-LID
LID-1
NDO-BSA
ND-O-LID
LID-1
ML2044
ML2028
Confirmed patients
MB
20
95% (19)
65% (13)
90% (18)
95% (19)
35% (7)
35% (7)
40% (8)
PB
11
63.6% (7)
36.4% (4)
45.5% (5)
36.4% (4)
72.7% (8)
63.6% (7)
54.5% (6)
At risk
HHC
42
21.4% (9)
0% (0)
35.7% (15)
2.4% (1)
31.0% (13)
23.8% (10)
31.0% (13)
Controls
TB
11
0% (0)
9.1% (1)
9.1% (1)
0% (0)
0% (0)
0% (0)
0% (0)
EC
10
10% (1)
0% (0)
10% (1)
10% (1)
0% (0)
20% (2)
10% (1)
Combined
21
4.8% (1)
4.8% (1)
9.5% (2)
4.8% (1)
0% (0)
9.5% (2)
4.8% (1)
1ELISA was determined as positive if mean OD of duplicate wells was >2 × EC mean OD. 2WBA were determined as positive if IFN concentration was >50 pg/mL.